2-Isopropyl-3-methylthiopyrazine
Common Name: |
2-Isopropyl-3-methylthiopyrazine |
IUPAC Name: |
2-methylsulfanyl-3-propan-2-ylpyrazine |
Molecular Formula: |
C8H12N2S |
SMILES: |
CC(C)C1=NC=CN=C1SC |
Inchi: |
1S/C8H12N2S/c1-6(2)7-8(11-3)10-5-4-9-7/h4-6H,1-3H3 |
Inchi Key: |
MUSIVZZZFRJWGI-UHFFFAOYSA-N |
Cas No: |
67952-59-4 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
168.26 |
Mass (g/mol) |
168.072 |
Molar Refractivity |
48.33 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
2 |
Rings |
1 |
TPSA |
51.08 |
Hetero Atoms |
3 |
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
6 |
Melting Point (°C) |
108.00 |
Boiling Point (°C@760.00mm Hg) |
317.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.043 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.50 |
LogP |
2.322 |
iLOGP |
2.28 |
XLOGP3 |
2.57 |
WLOGP |
2.32 |
MLOGP |
0.82 |
ESOL Log S |
-2.77 |
ESOL Solubility (mg/ml) |
0.283 |
ESOL Solubility (mol/l) |
0.002 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.29 |
Ali Solubility (mg/ml) |
0.09 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.97 |
Silicos-IT Solubility (mg/ml) |
0.18 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.50 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.838 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.166 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
1 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |